CAS: 6859-01-4; Isorhynchophylline

该化合物是一种化学化合物,主要来源于植物物种* Uncaria rhychophylla*,以亚洲草药中的传统医药用途而著称;该化合物的特点是复杂的四环结构,有助于其生物活动;该化合物具有一系列药理特性,包括...

结构式图片

欧盟法规

C&L通报

上下游产品

19H26N2O4C19H26N2O4 tert-butyl 2-oxohex-5-enoate tryptamine tert-butyl 2,5-dioxopentanoate

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2025092433-A1
    优先权日:2023-09-20
    标 题:Polypeptides for use in the synthesis of kratom alkaloids
    发明人:CASARETTO JOSE; AKTAR TARIQ A; ROTHSTEIN STEVEN; SOUBEYRAND ERIC
    权利人:MITRADYNE CORP
    摘要:Described herein are polypeptides encoding enzymes for the synthesis of monoterpene indole alkaloids. For example, the polypeptide comprises or consists of the sequence of SEQ ID NO: 1-68, or a variant thereof having at least 80% sequence identity to SEQ ID NO: 1-68, or a fragment of the polypeptide, or the variant thereof.

    专利号:US-9604987-B2
    优先权日:2011-03-23
    标题 :Synthesis of autophagy inducing compound and the uses thereof
    发明人:LI MIN; Liu liang feng; SONG JU XIAN; Zhang hong jie
    权利人:UNIV HONG KONG BAPTIST UNIV
    摘要:The present invention relates to a composition comprising compound of formula CB6 or CB8, n nthe pharmaceutically-acceptable carrier, solvent, the salts thereof or a combination thereof which is used to treat autophagy-associated diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, etc. The present invention also relates to a method of treating these diseases by administering a therapeutically-effective amount of the compound to the subject in need of the treatment. The present invention further relates to the use of this compound in preparation of the composition to treat the diseases.

    专利号:EP-4538367-A2
    优先权日:2023-09-20
    标 题:Polypeptides for use in the synthesis of kratom alkaloids

    专利号:US-2016046629-A1
    优先权日:2011-03-23
    标题:Synthesis of autophagy inducing compound and the uses thereof

    专利号:CN-120004790-A
    优先权日:2023-11-15
    标 题 :Synthesis method of spiro oxindole, ke Nayin and yohimbine alkaloid and derivatives thereof
    南昌贝塔生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    电话:0791-88613757👤
    ⚠️参考联系方式
    邮件:2584672360@qq.com
    销售经理: 李小姐经理
    联系电话:0791-88613757
    手机号码: 18970866941
    传真号码: 0791-88613757
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    青山湖区京东大道719号
    ⚠️ 未注册 · 未认证企业
    注册入口 声明: 数据来源:本内容基于各搜索引擎等公开数据整理,仅作展示用。请自行辨别 📄若企业需抹除相关内容或, 请联系方我们,我们即刻栓除。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology., 94(17), 1989 []
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知